These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 25197072)
1. Density-based separation in multiphase systems provides a simple method to identify sickle cell disease. Kumar AA; Patton MR; Hennek JW; Lee SY; D'Alesio-Spina G; Yang X; Kanter J; Shevkoplyas SS; Brugnara C; Whitesides GM Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14864-9. PubMed ID: 25197072 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of a density-based rapid diagnostic test for sickle cell disease in a clinical setting in Zambia. Kumar AA; Chunda-Liyoka C; Hennek JW; Mantina H; Lee SY; Patton MR; Sambo P; Sinyangwe S; Kankasa C; Chintu C; Brugnara C; Stossel TP; Whitesides GM PLoS One; 2014; 9(12):e114540. PubMed ID: 25490722 [TBL] [Abstract][Full Text] [Related]
3. A rapid, inexpensive and disposable point-of-care blood test for sickle cell disease using novel, highly specific monoclonal antibodies. Quinn CT; Paniagua MC; DiNello RK; Panchal A; Geisberg M Br J Haematol; 2016 Nov; 175(4):724-732. PubMed ID: 27605462 [TBL] [Abstract][Full Text] [Related]
4. Description of criteria for near miss in high-complexity obstetric population with sickle cell anemia: an observational study. Burgos Luna JM; Páez Rúa DM; Ruiz Ordoñez I; Fernández PA; Escobar Vidarte MF J Matern Fetal Neonatal Med; 2020 Mar; 33(6):941-946. PubMed ID: 30231783 [No Abstract] [Full Text] [Related]
5. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test. Steele C; Sinski A; Asibey J; Hardy-Dessources MD; Elana G; Brennan C; Odame I; Hoppe C; Geisberg M; Serrao E; Quinn CT Am J Hematol; 2019 Jan; 94(1):39-45. PubMed ID: 30290004 [TBL] [Abstract][Full Text] [Related]
6. Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania. Christopher H; Josephat E; Kaywanga F; Saul S; Mshana I; Kunambi P; Nasser A; Chamba C; Makani J; Nkya S Int J Lab Hematol; 2022 Oct; 44(5):959-965. PubMed ID: 35775883 [TBL] [Abstract][Full Text] [Related]
7. Severity in phenotypic expression of homozygous sickle cell disease (Hb.SS)--does hypermelanotic or hypomelanotic skin status of affected patients play a role? Bakare MO Med Hypotheses; 2011 May; 76(5):673-5. PubMed ID: 21288648 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of high performance liquid chromatography (HPLC) pattern and prevalence of beta-thalassaemia trait among sickle cell disease patients in Lagos, Nigeria. Adeyemo T; Ojewunmi O; Oyetunji A Pan Afr Med J; 2014; 18():71. PubMed ID: 25400838 [TBL] [Abstract][Full Text] [Related]